sonata
meda ab - zaleplon - poremećaji uvođenja i održavanja spavanja - psycholeptics - sonata je indicirana za liječenje bolesnika s nesanicom koji imaju poteškoće s zaspatom. to je indicirano samo kada je poremećaj ozbiljan, onemogućava ili podvrgava pojedincu ekstremnim nevoljama.
teriflunomid pharmascience 14 mg filmom obložene tablete
pharmascience international limited, lampousas, 1, nicosia, cipar - teriflunomid - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 14 mg teriflunomida
jimandin 100 mg filmom obložene tablete
medochemie ltd., constatinoupoleos str. 1-10, limassol, cipar - sitagliptinfosfat hidrat - filmom obložena tableta - 100 mg - urbroj: jedna tableta sadrži 100 mg sitagliptina u obliku sitagliptinfosfat hidrata
jimandin 25 mg filmom obložene tablete
medochemie ltd., constatinoupoleos str. 1-10, limassol, cipar - sitagliptinfosfat hidrat - filmom obložena tableta - 25 mg - urbroj: jedna tableta sadrži 25 mg sitagliptina u obliku sitagliptinfosfat hidrata
jimandin 50 mg filmom obložene tablete
medochemie ltd., constatinoupoleos str. 1-10, limassol, cipar - sitagliptinfosfat hidrat - filmom obložena tableta - 50 mg - urbroj: jedna tableta sadrži 50 mg sitagliptina u obliku sitagliptinfosfat hidrata
ridamec 1 mg/ml
chanelle pharmaceuticals manufacturing ltd., loughrea, co. galway, irska - moksidektin - oralna otopina - ovaca
fingolimod medochemie 0,5 mg tvrde kapsule
medochemie ltd., constatinoupoleos str. 1-10, limassol, cipar - fingolimodklorid - kapsula, tvrda - 0,5 mg - urbroj: svaka kapsula sadrži 0,5 mg fingolimoda (u obliku fingolimodklorida)
zeomax detoksikacijski prašak
novatech d.o.o., zagreb - mikronizirani zeolit za oralnu primjenu
lynparza
astrazeneca ab - olaparib - neoplazme jajnika - antineoplastična sredstva - jajnika cancerlynparza prikazan kao monoterapija za:podržava liječenje odraslih bolesnika s поздними (figo faze iii i iv) u genima brca1/2-mutirani (зародышевой linije i/ili somatskih) brzorezni epitela jajnika, masterbatch cijevi ili primarni перитонеальный rak, koji u odgovor (potpuno ili djelomično) nakon završetka prve linije na bazi platine kemoterapije. maintenance treatment of adult patients with platinum sensitive relapsed high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy. lynparza in combination with bevacizumab is indicated for the:maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy in combination with bevacizumab and whose cancer is associated with homologous recombination deficiency (hrd) positive status defined by either a brca1/2 mutation and/or genomic instability (see section 5. breast cancerlynparza is indicated as:monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline brca1/2-mutations who have her2-negative, high risk early breast cancer previously treated with neoadjuvant or adjuvant chemotherapy (see sections 4. 2 i 5. monotherapy for the treatment of adult patients with germline brca1/2-mutations, who have her2 negative locally advanced or metastatic breast cancer. pacijenti moraju prethodno bile tretirane s антрациклина i таксана u (neo)adjuvantne ili метастатический, ako pacijenti nisu prikladni za tih postupaka (vidi odjeljak 5. pacijenti s receptore hormona (h)-pozitivnog raka dojke treba također razvili ili nakon pre-hormonska terapija, ili se smatraju neprikladnim za endokrine terapije. adenocarcinoma of the pancreaslynparza is indicated as:monotherapy for the maintenance treatment of adult patients with germline brca1/2-mutations who have metastatic adenocarcinoma of the pancreas and have not progressed after a minimum of 16 weeks of platinum treatment within a first-line chemotherapy regimen. prostate cancerlynparza is indicated as:monotherapy for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc) and brca1/2-mutations (germline and/or somatic) who have progressed following prior therapy that included a new hormonal agent. in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with mcrpc in whom chemotherapy is not clinically indicated (see section 5.
singulair mini 4 mg oralne granule
organon pharma d.o.o., slavonska avenija 1c, zagreb, hrvatska - montelukastnatrij - granule - 4 mg - urbroj: jedna vrećica sadrži 4 mg montelukasta (u obliku montelukastnatrija)